Private Equity 3 Days

Last updated: June 16, 2026, 8:40 AM ET

Healthcare & Life Sciences

Private equity firms continue to deploy capital aggressively across the healthcare sector as Abry Partners closed an oversubscribed $780 million continuation vehicle for Centauri Health Solutions, enabling the Boston-based firm to retain one of its strongest healthcare assets amid a crowded deal environment. Meanwhile, H.I.G. Capital completed the sale of Celerion to THL Partners for $1.8 billion, marking a significant exit in the contract research organization space where demand for clinical pharmacology services remains elevated. Prime Radiant Partners made its inaugural $50 million growth equity investment in Cellares, a cell therapy manufacturing company, as new entrants seek to capitalize on the life sciences innovation wave. These moves come as senior dealmakers from Arlington, Bain Capital, EQT, and Permira converge on healthcare opportunities amid tech transformation and reimbursement shifts, with investors particularly focused on companies that can demonstrate measurable outcomes in an evolving regulatory landscape.

Technology & Data Infrastructure

The push into data center infrastructure continues to drive private equity interest in electric components procurement platforms, with Lead Edge Capital's acquisition of Elektrik representing a growing trend among investors seeking to capitalize on AI-driven demand. Cathay Capital acquired a majority stake in Equadis, the product data Saa S firm serving over 600 customers including Procter & Gamble, Unilever, and Nestlé, valuing the company's ability to manage complex product information flows across global supply chains. In a sign that private equity firms are rethinking traditional SaaS investment approaches amid AI disruption, investors are increasingly focusing on workflow ownership and business outcome delivery rather than pure software plays. This shift coincides with Apollo and Blackstone closing a $35 billion private credit deal to fund Anthropic's AI chip development, underscoring the massive capital requirements emerging in the artificial intelligence ecosystem.

Consumer & Retail Investments

European private equity activity spans diverse consumer sectors as L Catterton entered exclusive talks for a stake in Hyrox, the extreme fitness brand that has captured significant market share in the post-pandemic wellness economy. Birkenstock prepared its first bond sale in over five years, a €900 million issuance backed by L Catterton ownership, to fund aggressive share buybacks as the German footwear maker capitalizes on sustained demand for premium comfort footwear. Altor, Strawberry, and TDR Capital agreed to exit Nordic Leisure Travel Group for $846 million, divesting the operator of Ving, Spies, and Tjäreborg brands alongside 26 concept hotels across Southern Europe. These exits follow Apax Partners preparing residential warranty firm Oncourse for sale, carved out from American Water Works in 2021, as the firm looks to realize gains from its specialized insurance services platform.

Infrastructure & Defense Technology

Defense technology investments accelerated this week as BAE Systems committed €50 million to venture capital funds Lakestar and Expeditions, signaling increased corporate venture appetite in European defense tech following heightened geopolitical tensions. Playground Global's decade-long focus on hardware and deep tech appears prescient as the firm's investment thesis centered on scientific breakthroughs rather than software innovation attracts renewed attention from LPs seeking tangible assets. Meanwhile, ASML expressed interest in additional Mistral-style startup investments, suggesting semiconductor equipment leaders are looking to extend their ecosystem reach through strategic venture partnerships. These developments occur against a backdrop of European efforts to build self-reliant defense technology ecosystems and questions about whether the UK can deploy military AI at startup speed given traditional procurement cycles.

Financial Services & Payments

Cross-border financial services consolidation continued as Advent-backed Nuvei acquired Payoneer in a $2.75 billion take-private transaction, creating a formidable competitor in global payments and financial services with operations spanning multiple continents. Blackstone's Ancestry subsidiary arranged a $2.25 billion loan to refinance existing debt, with Bank of America leading the syndication as the genealogy business seeks to optimize its capital structure under private ownership. Morgan Stanley completed its exit from Brazos Delaware II for $1.6 billion, achieving an 8x EBITDA multiple based on projected 2027 earnings, demonstrating continued strong demand for mid-market platform investments. In credit markets, Blue Owl led Veld Capital's €355 million credit commitment vehicle, designed to capitalize on an existing pipeline of opportunities across European private equity.

Secondary Markets & Fundraising

The secondary market showed signs of continued strength as CalPERS appointed Anton Orlich to oversee its $250 billion alternatives portfolio, expanding his responsibilities to include private credit, real estate, infrastructure and other alternative programs beyond his existing private equity remit. Argosy doubled its fund size with a $145 million raise, positioning its small-deal-focused secondaries unit to write checks between $100,000 and $10 million as demand grows for specialized secondary strategies. EQT attracted approximately £5 billion ($6.7 in bank financing proposals to fund its potential take-private of Intertek, the British product-testing group, highlighting lenders' appetite for large-cap private equity transactions. These developments reflect growing sophistication among institutional investors in secondary allocation strategies, particularly as evergreen fund structures gain traction in the market.

Strategic Exits & Corporate Restructuring

Corporate carve-outs and strategic exits dominated headlines as Jardine Matheson pivoted to a private equity model, announcing a $500 million buyback and asset sales program that recasts the 194-year-old Hong Kong conglomerate as an active investor rather than traditional holding company. Sycamore Partners lost a suitor for Boots as Australia's Sigma Healthcare withdrew from the sale process for the UK pharmacy chain, narrowing the field for what has become one of the most closely watched retail transactions. Urs Wietlisbach split his family office operations in a succession move that separates the holdings of one of Partners Group's billionaire co-founders, creating a distinct unit within the broader family office structure. These moves come amid Elliott Investment Management building a near-5% stake in Bunzl and pressing the distribution company to launch substantial buybacks while reviewing its corporate structure.